List of Papers Published in 1999
Clinical Laboratory Division
1. Ando K, Matsuno Y, Kanai Y, Sakamoto M, Fujimoto H, Narabayashi M, Tobisu K. Primary low-grade lymphoma of mucosa-associated lymphoid tissue of the urinary bladder: a case report with special reference to the use of ancillary diagnostic studies. Jpn J Clin Oncol 1999;29:636-639.
2. Egashira Y, Shimoda T, Ikegami M. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55-61.
3. Fukushima N, Mukai K. Pancreatic neoplasms with abundant mucus production: emphasis on intraductal papillary-mucinous tumors and mucinous cystic tumors. Adv Anat Pathol 1999;6:65-77.
4. Hasegawa T, Shimoda T, Yokoyama R, Beppu Y, Hirohashi S, Maeda S. Intracortical osteoblastic osteosarcoma with oncogenic rickets. Skeletal Radiol 1999;28:41-45.
5. Hasegawa T, Matsuno Y, Shimoda T, Hasegawa F, Sano T, Hirohashi S. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Human Pathol 1999;1464-1473.
6. Kishi M, Tsukada T, Shimizu S, Hosono K, Ohkubo T, Kosuge T, Sugano K, Kanbe M, Obara T, Yamaguchi K. A novel splicing mutation (894-9 G A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1. Cancer Lett 1999;142:105-110.
7. Kodama K, Yokose T, Takahashi K, Minami H, Nagai K, Matsuno Y, Nishiwaki Y, Ochiai A. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the lung: a report of a case with pleural dissemination. Lung Cancer 1999;24:175-178.
8. Koyama T, Hasebe T, Tsuda H, Hirohashi S, Sasaki S, Fukutomi T, Imoto S, Umeda T, Moriya H, Mukai K. Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast. Jpn J Cancer Res 1999;90:294-300.
9. Kurisu Y, Shimoda T, Ochiai A, Nakanishi Y, Hirata I, Katsu K. Histologic and immuno-histochemical analysis of early submucosal invasive carcinoma of the colon and rectum. Pathol Int 1999;49:608-616.
10. Maekawa M, Sugano K, Kashiwabara H, Ushiama M, Fujita S, Yoshimori M, Kakizoe T. DNA methylation analysis using bisulfite treatment and PCR-single-strand conformation polymorphism in colorectal cancer showing microsatellite instability. Biochem Biophys Res Comm 1999;262:671-676.
11. Manda R, Kohno T, Matsuno Y, Takenoshita S, Kuwano H, Yokota J. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics 1999;61:5-14.
12. Mita T, Nakanishi Y, Ochiai A, Shimoda T, Kato H, Yamaguchi H, Toda G. Paraneoplastic vasculitis associated with esophageal carcinoma. Pathol Int 1999;49:643-647.
13. Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N, Kosugi S, Sugano K, Yamaguchi K. Two germline missense mutations at codon 804 and 806 of the RET protooncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999;90:1-5.
14. Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Hirohashi S. Heterotopic sebaceous glands in the esophagus: Histopathological and immunohistochemical study of a resected esophagus. Pathol Int 1999;49:364-368.
15. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers: a case control study. Oncology 1999;57:276-280.
16. Okano K, Shimoda T, Matsumura Y. Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases. J Gastroenterol 1999;34:334-340.
17. Osada T, Sakamoto M, Nagawa H, Yamamoto J, Matsuno Y, Iwamatsu A, Muto T, Hirohashi S. Acquisition of glutamine synthetase expression in human hepatocarcinogenesis. Cancer 1999;85:819-831.
18. Sato H, Hasegawa T, Abe Y, Sakai H, Hirohashi S. Expression of E-cadherin in bone and soft tissue sarcomas: A possible role in epithelial differentiation. Human Pathol 1999;30:1344-1349.
19. Sudo K, Maekawa M, Houki N, Okuda T, Akizuki S, Magara N, Kawano K. A novel in-frame deletion mutation in a case of lactate dehydrogenase (LD) H subunit deficiency showing an atypical LD isoenzyme pattern in serum and erythrocytes. Clin Biochem 1999;32:137-141.
20. Sugano K, Taniguchi T, Saeki M, Tsunematsu Y, Tomaru U, Shimoda T. Germline p53 mutation in a case of Li-Fraumeni syndrome presenting stomach cancer. Jpn J Clin Oncol 1999;29:513-516.
21. Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Clin Cancer Res 1999;5:1139-1146.
22. Tomizawa Y, Kohno T, Kiyama M, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Nakajima T, Yokota J. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene 1999;18:1007-1014.
23. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T, and NSAS-BC Pathology Section. The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. Jpn J Clin Oncol 1999;29:68-73.
24. Tsuda H, Takarabe T, Hasegawa T, Murata T, Hirohashi S. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Human Pathol 1999;30:1134-1139.
25. Hasegawa T, Hirohashi S. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology (in press)
Diagnostic Radiology Division
26. Furukawa H, Iwata R, Moriyama N, Kosuge T. Blood supply to the pancreatic head, bile duct, and duodenum:Evaluation by computed tomography during arteriography. Arch Surg 1999;134:1089-1090.
27. Furukawa H, Muramatsu Y, Fukushima N, Kosuge T. Carcinoma of the cystic bile duct:MRCP and CT appearance. Am J Roentgenol 1999;173:1141.
28. Furukawa H, Muramatsu Y, Moriyama N. Does MR cholangiopancreatography contribute to the early diagnosis of pancreatic carcinoma? Pancreas 1999;19:408-409.
29. Furukawa H, Okada S, Kakizoe T. Early diagnosis of pancreatic cancer. Hepato-Gastroenterol 1999;46:4-7.
30. Imoto S, Murakami K, Ikeda H, Fukukita H, Moriyama N. Mammary Lymphoscintigraphy with various radiopharmaceuticals in breast cancer. Annal Nucl Med 1999;13:325-329.
31. Kakinuma R, Ohmatsu O, Kaneko M, Eguchi K, Naruke T, Nishiwaki Y, Suzuki A, Moriyama N. Detection failures in spiral CT screening for lung cancer: Analysis of CT findings. Radiology 1999;212:61-66.
32. Nawano S, Murakami K, Moriyama N, Takeo H, Shimura K. Computer-Aided diagnosis in full digital mammography. Invest Radiol 1999;34:310-316.
33. Okuda K, Matsutani S, Takayasu K. Hepatobiliary and pancreatic: an alcoholic man with a lesion in the splenic hilum. J Gastroenterol Hepatol 1999;14:197-198.
34. Takayasu K, Muramatsu Y, Asai S, Muramatsu Y, Kobayashi T. CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminaly study. Am J Roentgenol 1999;173:1219-1224.
35. Takayasu K, Muramatsu Y, Iwata R. Hepatic arterial supply from the cystic artery:findings on arteriography, CT arteriography, and CT during arterial portography. Am J Roentgenol 1999;172:659-660.
36. Takayasu K, Okuda K. Hepatobiliary and pancreatic thread-like vessels in an arteriogram. J Gastroenterol Hepatol 1999;14:103-104.
37. Takayasu K, Yoshie K, Muramatsu Y, Iwata R, Nakanishi Y, Sakamoto M, Fukuda H, Sakake M, Moriyama N, Makino Y. Haemdynamic changes in non-alcoholic (viral) liver cirrhosis studied by computed tomography arterial portography and CT arteriography. J Gastroenterol Hepatol 1999;14:908-914.
38. Furukawa H, Iwata R, Moriyama N, Kosuge T. CT with selective intraarterial contrast enhancement for pancreaticoduodenal tumors: Early clinical experience in evaluating blood supply and detectability. Am J Roentgenol (in press)
39. Furukawa H, Shimada K, Iwata R, Moriyama N. A replaced common hepatic artery running through the pancreatic parenchyma. Surgery (in press)
40. Iinuma G, Ushio K, Ishikawa T, Nawano S, Sekiguchi R, Satake M. Comparison of conventional radiography and digital radiography ushing a 4 million pixel CCD for the diagnosis of gastric cancers. Radiology (in press)
41. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takayasu K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT and resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. Am J Roentgenol (in press)
Endoscopy Division
42. Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, Yokota T. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions. Gastrointest Endosc 1999;50:560-563.
43. Kanamoto A, Kato H, Tachimori Y, Watanabe H, Nakanishi Y, Kondo H, Yamaguchi H, Gotoda T, Muro K, Matsumura Y. No prognostic significance of p53 expression in esophageal squamous cell carcinoma. J Surg Oncol 1999;72:94-98.
44. Kobayashi T. CT-guided bronchoscopy for minute peripheral lung cancer: From diagnosis to future therapeutic strategies. Rev Oncol 1999;1(Supl II):41-45.
45. Okamoto N, Suzuki T, Kaneko M. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan. Lung Cancer 1999; 25 :77-85.
46. Gotoda T, Saito D, Kondo H, Ono H, Oda I, Fujishiro M, Yamaguchi H. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. J Gastroenterol 1999;34(supl XI):91-96.
47. Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut (in press)
48. Kondo H, Gotoda T, Ono H, Yamaguchi H, Oda I, Saito D, Yoshida S. Early gastric cancer: endoscopic mucoal resection. Annali Italiani di Chirurgia (in press)
Breast and Endocrinology Division
49. Abe K, Watanabe T. Report of the twelfth international symposium of the foundation for promotion of cancer research: Basic and clinical research in breast cancer. Jpn J Clin Oncol 1999;29:399-402.
50. Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Simoyama M, for the JCOG Breast Cancer Study Group. A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: A Japan Clinical Oncology Group (JCOG) Study 9113. Jpn J Clin Oncol 1999;29:23-27.
51. Tokuda Y, Watanabe T, Omuro Y, Ando M, Katsumata N, Okumura A, Ohta M, Fujii H, Sasaki Y, Niwa T, Tajima T. Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Br J Cancer 1999;81:1419-1425.
52. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. Jpn J Clin Oncol 1999;29:413-420.
53. Zhang G, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999;19:1427-1432.
54. Zhang G, Adachi I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlation with clinicopathological features and prognosis. Int J Oncol 1999;14:71-77.
55. Katsumata N, Watanabe T, Tominaga T, Ogawa M, Adachi I, Enomoto K, Kajiwara T, Kusama M, Yamada Y, Abe O. Phase II study of KRN8602, 3・deamino-3・morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride, MX2-HCI in patients with metastatic breast cancer. Cancer Chemother Pharmacol 1998;43:441-444.
Gastrointestinal Oncology Division
56. Boku N, Ohtsu A, Shimada Y, Shirao K, Seki S, Saito H, Sakata Y, Hyodo I. Phase II study of a combination of Irinotecan and Cisplatin against metastatic gastric cancer. J Clin Oncol 1999;17:319-323.
57. Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi T, Shirasaka T. Pharmacokinetic study of S-1: a novel oral fluorouracil antitumor drug. Clin Cancer Res 1999:2000-2005.
58. Matsumura Y, Yokoyama M, Kataoka K, Okano T, Sakurai Y, Kawaguchi T, Kakizoe T. Reduction of the side effectts of an antitumor agent, KRN5500, by incorporation of the drug into polymeric micelles. Jpn J Cancer Res 1999;90:122-128.
59. Muto M, Hasebe T, Muro K, Boku N, Ohtsu A, Fujii T, Ono M, Tajiri H, Mukai K, Yoshida S. Primary squamous cell carcinoma of the stomach; a case repot with a review of Japanese and Western literature. Hepato-Gastroenterol 1999;46:3015-3018.
60. Muto M, Ohtsu A, Miyamoto S, Muro k, Boku N, Ishikura S, Satake M, Ogino T, Tajiri H, Yoshida S. Concurrent chemoradiotherapy for esophageal carcinoma patinets with malignant fistulae. Cancer 1999;86:1406-1413.
61. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Kaneko K, Nakamura A. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-2921.
62. Satoh T, Tsushima K, Saitoh S, Hizawa Y, Tamura Y, Fukuda S, Yamada Y, Tohno H, Takasugi T, Sakata Y, Munakata A. A case of advanced esophageal cancer showing a long-term complete response with chemotherapy with nedaplatin alone. Jpn J Clin Oncol 1999:106-108.
63. Ando Y, Saka H, Ando M, Sawa Y, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity;a pharmacogenetic analysis. Lancet (in press)
Hematology Division
64. Ando M, Narabayashi M, Watanabe T, Kamiya Y, Togitani K, Tanosaki R, Kobayashi Y, Takenaka T, Tobinai K, Adachi I. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide and anthracyclines. Jpn J Clin Oncol 1999;29:28-32.
65. Hirose M, Hamano S, Tobinai K, Kuroda Y. Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class I, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines. J Immunother 1999;22:237-244.
66. Kobayashi Y, Nakayama M, Uemura N, Takeyama K, Tobinai K, Takenaka T, Choi S, Satoh H, Mori S, Asano S. Analysis of myelodysplastic syndrome clones arising after multiple myeloma: A case study by correlative interphase cytogenetic analysis. Jpn J Clin Oncol 1999;29:374-377.
67. Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Jpn J Clin Oncol 1999;29:340-348.
68. Miyawaki S, Tanimoto M, Kobayashi T, Minami S, Tamura J, Omoto E, Kuriyama K, Hatake K, Saito K, Kanamaru A, Oh H, Ohtake S, Asou N, Sakamaki H, Yamada O, Jinnai I, Tsubaki K, Takeyama K, Hiraoka A, Matsuda S, Takahashi M, Shimazaki C, Adachi K, Kageyama S, Sakura T, Ohno R. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Int J Hematol 1999;70: 97-104.
69. Murayama T, Koizumi T, Das H, Kobayashi Y, Kajimoto K, Sugimoto T, Imoto S, Hishimura S, Nakagawa T. Soluble FAS ligand in natural killer cell lymphoma. Am J Hematol 1999;62:253-255.
70. Nakata M, Matsuno Y, Katsumata N, Takenaka T, Kobayashi Y, Yokozawa T, Kagami Y, Ikeda H, Kaneko A, Tobinai K. Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma. Leukem Lymph 1999;32:533-543.
71. Narabayashi M, Takeyama K, Fukutomi T, Tokuda Y, Tajima T, Okumura A, Chou T, Sano M, Makino H, Igarashi T, Sasaki Y, Imoto S, Ogura M, Murai H, Okamoto S, Ikeda T, Kasai M, Yokozawa T, Tobinai K. A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Jpn J Clin Oncol 1999;29:285-290.
72. Okamoto S, Takahashi S, Wakui M, Ishida A, Tanosaki R, Ikeda Y, Asano S. Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation. Br J Haematol 1999;104:569-573.
73. Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Harada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H, Shimoyama M. Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Jpn J Clin Oncol 1999;29:485-489.
74. Ando M, Yokozawa T, Sawada J, Takaue Y, Togitani K, Kawahigashi N, Narabayashi M, Takeyama K, Tanosaki R, Mineishi S, Kobayashi Y, Watanabe T, Adachi I, Tobinai K. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant (in press)
75. Itoh K, Ohtsu T, Sasaki Y, Ogura M, Morishima Y, Kasai M, Chou T, Yoshida K, Ohno T, MIzorogi F, Uike N, Sai T, Taniwaki M, Ikeda S, Tobinai K. Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP in aggressive non-Hodgkin's lymphoma. Leukem Lymph (in press)
76. Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K, Shimoyama M and the Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG): Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: A multicenter phase II study (JCOG8905). Jpn J Clin Oncol (in press)
77. Tobinai K. Adult T-cell leukemia-lymphoma. In: Abeloff MD ea, ed. Clinical Oncology, second edition. New York: Churchill Livingstone Inc. (in press)
78. Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma (MCL): A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood (in press)
79. Yokozawa T, Towatari M, Iida H, Takeyama K, Tanimoto M, Kiyoi H, Motoji T, Asou N, Takeuchi M, Kobayashi Y, Miyawaki S, Kodera T, Ohno R, Saito H, Naoe T: Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia. Leukemia (in press)
Hematopoeitic Stem Cell Transplantation Team
80. Kawano Y, Takaue Y. Is filgrastim as useless after PBSC transplantation for adults as it could be for children? Blood 1999;93:3566.
81. Kawano Y, Takaue Y, Watanabe T, Abe T, Okamoto Y, Iwai A, Iwai T, Watanabe A, Ito E, Makimoto A, Nakagawa R, Watanabe H, Sato J, Suenaga K, Suzuya H, Ohnishi T, Kanamaru S, Kaneko M, Kuroda Y. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors. Cancer Res 1999;59:3321-3324.
82. Takaue Y, Tanosaki R. Progress in cell therapy in Japan 1999. Jpn J Clin Oncol 1999;29:117-118.
83. Takaue Y, Eguchi H, Kawano Y, Watanabe A, Mugishima H, Kaneko M. Transplantation with PBSC, manipulated or unmanipulated, for the treatment of childhood cancer. In: Dicke KA, Keating A, eds. Autologous Blood and Marrow Transplantation. Charlottesville: Carden Jennings Publishing, 1999:417-421.
84. Watanabe T, Kawano Y, Kanamaru S, Ohnishi T, Kaneko S, Wakata Y, Nakagawa R, Makimoto A, Kuroda Y, Takaue Y, Talmadge J. Endogenous interleukin (IL)-8 surge in granulocyte-colony stimulating factor induced peripheral blood stem cell mobilization. Blood 1999;93:1157-1163.
85. Watanabe T, Kawano Y, Watanabe A, Takaue Y. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience. Haematologica 1999;84:167-176.
86. Yano M, Watanabe A, Kawano Y, Watanabe T, Takaue Y. Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells? Bone Marrow Transplant 1999;23: 847-848.
87. Horikoshi Y, Mimaya J, Takaue Y, Kawano Y, Watanabe A, Watanabe T, Sekine I, Nishikawa K, Tsunematsu Y, Endo M, Eguchi H, Koyama T, Kawakami K, Oka T, Matsushita T, Koizumi S, Ohira M, Fujimoto T. Feasibility study of autologous peripheral blood stem cell transplantation for the treatment of childhood acute myelogenous leukemia. Jpn J Clin Oncol (in press)
88. Kawano Y, Takaue Y, Watanabe T, Okamoto Y, Abe T, Kuroda Y, Watanabe A. Autologous and allogeneic transplantation with blood CD34+ cells: a pediatric experience. Hematopoietic Stem Cell Therapy (in press)
89. Makimoto A, Takaue Y, Abe T, Kajiume T, Okamoto Y, Sato J, Nakagawa R, Watanabe H, Watanabe T, Kawano Y, Kuroda Y, Sweet L. Comparative evaluation of equipment with a Baxter CS-3000 cell separator for collecting peripheral blood cells from children. J Hematother (in press)
90. Watanabe T, Kajiume T, Abe T, Kawano Y, Iwai A, Iwai T, Takaue Y, Kuroda Y. Allogeneic peripheral blood stem cell transplantation in children with hematological malignancies from HLA-matched siblings. Med Pediatr Oncol (in press)
91. Watanabe T, Mineishi S, Kawano Y, Takaue Y. Partially matched transplants with allogeneic CD34+ blood cells. Leukem Lymph (in press)
Hepatobiliary and Pancreatic Oncology Division
92. Koike K, Shimotouno K, Okada S, Okamoto H, Hayashi N, Ueda K, Kaneko K, Koike K, Yokosuka O, Chiba T, Marusawa H, Hino O, Utida T, Omata M, Juji T, Nojiri N, Takada K, Miyamura T, Osuga T, Ito Y. Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan. Jpn J Cancer Res 1999;90:1270-1272.
93. Kosakamoto H, Okada S, Ueno H, Okusaka H, Ikeda M, Tanaka N, Yoshimori M, Matsuno Y. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy. Hepato-Gastroenterol 1999;46:2621-2624.
94. Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Clinicopathological features in misdiagnosed pancreatic carcinoma. Hepato-Gastroenterol 1999;46:2983-2985.
95. Okada S. Non-surgical treatments of pancreatic cancer. Int J Clin Oncol 1999;4:257-266.
96. Okada S. Local ablation therapy of hepatocellular carcinoma. Semin Liver Dis 1999;19:323-328.
97. Okada S, Sakata Y, Matsuno S, Kurihara M, Sasaki Y, Ohashi Y, Taguchi T, for the Cooperative Group of Docetaxel for Pancreatic Cancer in Japan. Phase II study of docetaxel in patients with metastatic pancreatic cancer: A Japanese cooperative study. Br J Cancer 1999;80:438-443.
98. Sawada M, Okada S. Serum prostate-specific antigen levels are not elevated in most of the patients with advanced pancreatic adenocarcinoma. Jpn J Clin Oncol 1999;29:365.
99. Uehara H, Nakaizumi A, Tatsuta M, Baba M, Takenaka A, Uedo N, Sakai N, Yano H, Ishii H, Ohigashi H, Ishikawa O, Okada S, Kakizoe T. Diagnosis of pancreatic cancer by detecting telemerase activity in pancreatic juice: Comparison with K-ras mutations. Am J Gastroenterol 1999;94:2513-2518.
100. Fujishiro M, Okada S, Ueno H, Okusaka T, Ikeda M, Watanabe H, Tanaka N. Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer. Hepato-Gastroenterol (in press)
101. Ikeda M, Okada S, Ueno H, Okusaka H, Tanaka N, Kuriyama H, Yoshimori M. A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer. Hepato-Gastroenterol (in press)
102. Nose H, Okada S, Okusaka T, Furuse J, Yoshino M, Ogoshi K, Kato T, Miyaji M, Hoshino M, Ariyama J, Suyama M, Karasawa E, Yoshimori M. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study. Hepato-Gastroenterol (in press)
103. Okada S, Abo T. Natural regression of hepatocellular carcinoma. J Gastroenterol Hepatol (in press)
104. Okada S. How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma? J Gastroenterol (in press)
105. Okada S. How to manage hepatic vein tumor thrombus in hepatocellular carcinoma. J Gastroenterol Hepatol (in press)
106. Okada S, Okuda K. Management of hepatocellular carcinoma: current practice and future options. Int J Gastroenterol (in press)
107. Okusaka T, Okada S, Ueno H, Ikeda M, Yoshimori M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Iwata R, Furukawa H, Moriyama N, Sakamoto M, Hirohashi S. Evaluation of therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology (in press)
108. Tanaka N, Okada S, Ueno H, Okusaka T, Ikeda M. The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer. Pancreas ;20.
109. Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Hepato-Gastroenterol (in press)
Pain Medicine and Palliative Care Division
110. Shimoyama M, Shimoyama N, Gorman A, Elliott K, Inturrisi C. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain 1999;81:85-93.
111. Nishino T, Shimoyama N, Ide T, Isono S. Experimental pain auguments dyspnea, but not vice versa, in human volunteers. Anesthesiology (in press)
112. Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain (in press)
Pediatric Oncology Division
113. Kawa K, Ohnuma N, Kaneko M, Yamamoto K, Etoh T, Mugishima H, Ohhira M, Yokoyama J, Bessho F, Honna T, Yoshizawa J, Nakada K, Iwafuchi M, Nozaki T, Mimaya J, Sawada T, Nakamura T, Miyata H, Yamato Y, Tsuchida Y. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months. J Clin Oncol 1999;17.
Psycho-Oncology Division
114. Akechi T, Kugaya A, Okamura, Yamawaki S, Uchitomi Y. Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 1999;17:42-48.
115. Akechi T, Kugaya A, Okamura H, Nakano T, Okuyama T, Mikami I, Shima Y, Yamawaki S, Uchitomi Y. Suicidal thoughts in cancer patients:Clinical experience in psycho-oncology. Psychiatry Clin Neurosci 1998;53:569-573.
116. Nakano T, Kugaya A, Akechi T, Mikami I, Okuyama T, Okamura H, Uchitomi Y. Algorithm for the treatment of major depression in patients with advanced cancer. Psychiatry Clin Neurosci 1999;53:S61-S65.
117. Kugaya A, Akechi T, Nakano T, Okamura H, Shima Y, Uchitomi Y. Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Support Care Cancer 1999;7:432-436.
118. Kugaya A, Akechi T, Okamura H, Mikami I, Uchitomi Y. Correlates of depressed mood in ambulatory head and neck cancer patients. Psycho-Oncology 1999;8:494-499.
119. Mikami I, Akechi T, Kugaya A, Okuyama T, Nakano T, Okamura H, Yamawaki S, Uchitomi Y. Screening for nicotine dependence among smoking-related cancer patients. Jpn J Cancer Res 1999;90:1071-1075.
120. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y. Factors correlated with fatigue in disease-free breast cancer patients:Application of the cancer fatigue scale. Support Care Cancer (in press).
121. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Development and validation of the cancer dyspnoea scale: a multidimensional, brief, self-rating scale. Br J Cancer (in press).
122. Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Marughichi M, Hosaka T, Uchitomi Y. Development and validation of the Cancer Fatigue Scale: a brief, three dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Sympt Manage (in press).
Thoracic Oncology Division
123. Arioka H, Nishio K, Ishida T, Fukumoto H, Fukuoka K, Nomoto T, Kurokawa H, Yokote H, Abe S, Saijo N. Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA-transfected Human Lung Cancer Cell. Jpn J Cancer Res 1999;90:108-115.
124. Fukumoto H, Nishio K, Ohta S, Hanai N, Fukuoka K, Ohe Y, Sugihara K, Kodama T, Saijo N. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo. Int J Cancer 1999;82:759-764.
125. Kanzawa F, Nishio K, Fukuoka K, Sunami T, Saijo N. In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model. Cancer Chemother Pharmacol 1999;43:353-363.
126. Kunitoh H, Sekine I, Kubota K, Tamura T, Shinkai T, Kodama T, Saijo N, Naruke T, Yamaguchi N. Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers. Cancer 1999;86:1182-1188.
127. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 1999;6:33-37.
128. Nishio K, Fukuoka K, Fukumoto H, Sunami H, Iwamoto Y, Suzuki T, Usuda J, Saijo N. Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells. Int J Oncol 1999;14:461-469.
129. Nishio K, Nakamura T, Koh Y, Suzuki T, Fukumoto H, Saijo N. Drug resistance in lung cancer. Curr Opn Oncol 1999;11:109-115.
130. Nishio K, Saijo N. Cytoskeletons and antimitotic agents developed in Japan. Anti-Cancer Drug Design 1999;14:133-141.
131. Saijo N. Antiemetic therapy. Jpn J Clin Oncol 1999;29:57-58.
132. Sekine I, Tamura T, Kunitoh H, Kubota K, Shinkai T, Kamiya K, Saijo N. Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer. Ann Oncol 1999;10:731-733.
133. Sunami T, Nishio K, Kanzawa F, Fukuoka K, Kudoh S, Yoshikawa J, Saijo N. Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells. Cancer Chemother Pharmacol 1999;43:394-401.
134. Tanaka T, Uchiumi T, Nomoto M, Kohno K, Kondo T, Nishio K, Saijo N, Kuwano M. Cellular balance of glutathione levels through the expression of g-glutamylcysteine synthetase and glutathione thiol transferase genes in human hepatic cells resistant to a glutathione poison. Biochim Biophys Acta 1999:367-377.
135. Yamamoto N, Tamura T, Yamamoto N, Fukuoka M, Saijo N. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience. Int J Oncol 1999;15:737-741.
136. Fukumoto H, Tamura T, Kamiya Y, Usuda J, Suzuki T, Kanzawa F, H-J K, Ohe Y, Saijo N, Nishio K. Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01. Invest new drugs(DRUG) (in press)
137. Fukuoka K, Nishio K, Fukumoto H, Arioka H, Kurokawa H, Ishida T, Iwamoto Y, Tomonari A, Suzuki T, Usuda J, Narita N, Saijo N. Ectopic p16INK expression enhances CPT-11-induced apoptosis through the increased delay in S phase progression in human non-small cell lung cancer cells. Int J Cancer (in press)
138. Harada T, Takaba K, Hara T, Yamamoto N, Tamura T, Saijo N. Inhibitory effects of repeated intravenous injections of dexamethasone on plumonary toxicity of a new mitomycin C analogue, KW-2149, in a novel rat model. J Toxicol Sciences (in press)
139. Naruse I, Nishio K, Saijo N. Antitumour activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) iressa (ZD1839) in non-p-glycoprotein-mediated multidrug resistant cells in vitro and in vivo. Clinical Cancer Res (in press)
140. Suzuki T, Sasaki H, Hyo-Jeng K, Agui M, Tatsumi Y, Tanabe S, Terada M, Saijo N, Nishio K. Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts. GENE (in press)
141. Usuda J, Saijo N, Fukuoka K, Fukumoto H, Hyo-Jeng K, Nakamura T, Koh Y, Suzuki T, Koizumi F, Tamura T, Kato H, Nishio K. Molecular determinants of UCN-01 induced growth inhibition in human lung cancer cells. Int J Cancer (in press)
Radiation Oncology Division
142. Ikeda H, Ishikura S, Oguchi M, Niibe H, Yorozu A, Nakano K, Fuwa N, Watanabe S, Teshima T. Analysis of 57 nonagenarian cancer patients treated by radical radiotherapy: A survey of 8 institutions. Jpn J Clin Oncol 1999;29:378-381.
143. Ikeda H, Ogino T, Ishikura S, Kawashima M, Imai M, Ito Y, Kagami Y, Tokuuye K, Sumi M, Murayama M. Radiation therapy for head and neck cancers. Japan/U.S. Cancer Therapy Symposium. Hiroshima 1999:30-32.
144. Ishikura S, Ogino T, Ono M, Arai T, Sugito M, Shimizu W, Kawashima M, Imai M, Ito Y, Ikeda H. Preliminary results of pelvic autonomic nerve-preserving surgery combined with intraoperative and postoperative radiation therapy for patients with low rectal cancer. Jpn J Clin Oncol 1999;29:429-433.
145. Kawashima M, Ikeda H, Yorozu A, Niibe H, Teshima T, Fuwa N, Oguchi M, Nakano K, Kobayashi T. Multi-institutional survey of radiotherapy for octogenarian squamous cell carcinoma of the thoracic esophagus: Compared with the results of surgery reported from Japan. Nippon Acta Radiologica 1999;59:72-78.
146. Kawashima M, Ogino T, Fujii H, Ishikura S, Ito Y, Ikeda H. Local-regional control by conventional radiotherapy according to tumor volume in patients with squamous cell carcinoma of the pharyngolarynx. Jpn J Clin Oncol 1999;29:467-473.
147. Tanisada K, Teshima T, Inoue T, Owen J, Hanks G, Abe M, Ikeda H, Sato S, Kawachi K, Yamashita T, Nishio M, Hiraoka M, Hirokawa Y, Oguchi M, Masuda K. National average for the process of radiation therapy in Japan by Patterns of Care Study. Jpn J Clin Oncol 1999;29:209-213.
148. Teshima T, Ikeda H, Abe M, Hanks G, Owen J, Oguchi M, Hirokawa Y, Hiraoka M, Nishio M, Yamashita T, Naito A, Okazaki Y, Inoue. Patterns of Care Study of radiation therapy for uterine cervix cancer in Japan: The influence of age on the process. Int J Clin Oncol 1999;4:9-16.
149. Sumi M, Ikeda H, Tokuuye K, Kagami Y, Murayama S, Tobisu K, Kakizoe T. The external radiotherapy with 3D-conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma. Int J Radiol Oncol Phys Biol (in press)
150. Tokuuye K, Tokita N, Akine Y, Nakayama H, Sakurai H, Kobayashi T, Kanda K. Comparison of radiation effects of gadolinium and boron neutron capture reactions. Stralenthrer Onkol (in press)
Anesthesiology and Pain Clinic Division
151. Saito T, Kaneko A, Muramatu Y, Den S. Difficult tracheal intubation in patients with retinoblastoma caused by 13q deficiency. Jpn J Clin Oncol 1998;28:507-510.
152. Saito T, Naruge T, Carney E, Hiraga K. The new NCC double lumen intrabronchial tube for permanently tracheostomized patients. Anesthesiology 1998;89:1038-1039.
153. Saito T, Sessler D, Fujita K, Jeffrey R. Thermoregulatory effect of spinal and epidural anesthesia during cesearal delivery. Regional Anesthesia 1998;23:418-423.
154. Saito T, Den S, Hiraga K, Carlsson O. Fluid communication between the thoracic and lumbar paravertebral regions. Surg Rad Anat 1998;29:206-212.
155. Saito T, Den S, Hiraga K, Carlsson O. The difference between delayed extubation and tracheostomy in post-operative sleep apnea after glossectomy or laryngectomy. Jpn J Clin Oncology 1999;29:127-131.
156. Saito T, Naruge T, Yokokawa Y, Hiraga K. New NCC double lumen intrabronchial tube for tracheostomized patients. Int J Anesthesiol 1999;3:1-2.
Breast Surgery Division
157. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Uchiyama N, Nanasawa T, Tsuda H. Constrast-enhanced computed tomography detection of occult breast cancer presenting as axillary masses. Breast Cancer Res Treat 1999;55:97-101.
158. Kuno T, Fukutomi T, Akashi-Tanaka S, Nanasawa T, Kanai Y, Tsuda H, Nomizu T, Miki Y. Bilateral nonpalpable breast carcinoma in a patient with BRCA1 germ line mutation and past hisory of osteosarcoma. Breast Cancer 1999;6:51-54.
159. Noguchi S, Kasugai T, Miki Y, Fukutomi T, Emi M, Nomizu T. Clinicopathologic analysis of BRCA1 -or BRCA2- associated hereditary breast carcinoma in Japanese women. Cancer 1999:2200-2205
160. Saimura M, Fukutomi T, Tsuda H, Akashi-Tanaka S, Nanasawa T. Breast carcinoma with osteoclast-like giant cells:A case report and review of the Japanese literature. Breast Cancer 1999;6:121-126.
161. Saimura M, Fukutomi T, Tsuda H, Sato H, Miyamoto K, Akashi-Tanaka S, Nanasawa T. Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor. J Sug Oncol 1999;71:101-105.
162. Tsuda H, Takarabe T, Fukutomi T, Hirohashi S. der(16)t(1;16)/der(1;16)in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis. Genes Chromosomes Cancer 1999;24:72-77.
163. Ashida A, Fukutomi T, Tsuda H, Akashi-Tanaka S, Ushijima T. Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with BRCA1 germline mutation. Jpn J Clin Oncol ;30.
164. Higashi H, Fukutomi T, Watanabe T, Adachi I, Narabayashi M, Shibui S, Hokamura N, Akashi-Tanaka S. Seven cases of breast cancer recurrence in the central nervous system without visceral metastases. Breast Cancer (in press)
165. Shimizu C, Fukutomi T, Tsuda H, Akashi-Tanaka S, Watanabe T, Nanasawa T, Sugihara K. c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues. J Surg Oncol (in press)
166. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S. Large central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to recurrences in lung and brain. Am J Surg Pathol (in press)
Colorectal Surgery Division
167. Koga H, Moriya Y, Akasu T, Fujita S. The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. Eur J Surg Oncol 1999;25:292-296.
168. Havenga K, Enker W, Norstein J, Moriya Y, RJ Heald, van Houwelingen H, van de Velde C. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an internayional analysis of 1411 patients. Eur J Surg Oncol 1999;25:368-374.
169. Mass K, Moriya Y, Kenter G, Trimbos V, van de Velde C. Plea for preservation of the autonomic nerves. Lancet 1999;354:772-773.
170. Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol (in press)
171. Akasu T, Kondo H, Moriya Y, Fujita S, Gotoda T, Sugihara K, Kakizoe T. Endorectal ultrasonography and treatment of early stage rectal cancer. World J Surg (in press)
172. Akasu T, Yokoyoyama T, Fujita S, Moriya Y, Sugihara K, Kakizoe T. Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot study. Hepato-Gastroenterol (in press)
173. Fujii K, Moriya Y, Akasu T, Fujita S. Dermatomyositis accompanied by rectal cancer: Report of a case. Surg Today (in press)
174. Iwasaki Y, Moriya Y, Akasu T, Fijita S. En bloc surgery for colon: Report of a case. Surg Today (in press)
175. Yamaguchi T, Moriya Y, Fujii T, Kondo H, Oono Y, Shimoda T. Anal canal squamous cell carcinoma in situ, clearly demonstreated by Indigo Carmine Dye Spraying. Dis Colon Rectum (in press)
Dermatology Division
176. Kageshita T, Yamamoto A, Yamazaki N, Ishihara K, Ono T. Low frequency of neutralizing antibodies against natural interferon-g during adjuvant therapy for Japanese patients with melanoma. J Dermatol Science 1999;19:208-212.
177. Yamazaki N, Yamamoto A, Wada T, Ishikawa M. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma. Jpn J Dermatol 1999;26:489-493.
178. Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy. Jpn J Dermatol 1999;26:311-316.
179. Takata M, Hashimoto K, Mehregan P, Lee M, Yamamoto A, Mohri S, Ohara K, Takehara K. Genetic changes in sweat gland carcinomas. J Cutan Pathol (in press)
Esophageal Surgery Division
180. Hokamura N, Kato H, Watanabe H, Tachimori Y, Shimoda T, Nakanishi Y. Fulminant nonocclusive mesenteric ischemia developing just after esophagectomy. Hepato-Gastroenterol 1999;46:2865-2867.
181. Nishimaki T, Tanaka O, Ando N, Ide H, Watanabe H, Shinoda M, Takiyama W, Yamana H, Ishida K, Isono K, Endo M, Ikeuchi T, Mitomi T, Koizumi H, Imamura M, Iizuka T. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 1999;68:2059-2064.
Gastric Surgery Division
182. Katai H, Maruyama K, Sasako M, Sano T. Incidence of nodal metastasis around the superior border of the pancreas based on the number of metastatic perigastric nodes. Gastric Cancer 1999;2:115-117.
183. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery?: Fundamental and new information on lymph-node dissection. Langenbeck's Arch Surg 1999;384:149-157.
184. Nakajima T, Nashimoto A, Kitamura M, Kito T, Iwanaga T, Okabayashi K, Goto M, Gastric Cancer Surgical Study Group. Adjuvant mytomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial. Lancet 1999;354:273-277.
185. Sano T, Mudan SS. No advantage of reoperation for positive resection margins in node positive gastric cancer patients? Jpn J Clin Oncol 1999;29:283-284.
186. Sano T, Sasako M, Katai H, Maruyama K. Randomized controlled trials on adjuvant therapy for gastric cancer: Japanese experience. In: Nakajima T, Yamaguch T, eds. Multimodality Therapy for Gastric Cancer. Tokyo: Springer Verlag, 1999:7-16.
187. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of new UICC-TNM classification for gastric carcinoma. Cancer (in press)
188. Sano T. Treatment of primary gastric lymphoma: experience in the National Cancer Center Hospital Tokyo. In: Fischbach, ed. Recent results in Cancer Research vol 156 Gastrointestinal Lymphoma. Berlin: Springer-Verlag (in press)
189. Sano T, Katai H, Sasako M, Maruyama K. Gastric lymphography and detection of sentinel nodes. In: Schlag P, ed. Recent Results in Cancer Research vol 157 Sentinel Node Detection. Berlin: Springer-Verlag (in press)
190. Sasako M. What is reasonable treatment for gastric adenocarcinoma. J Gastroenterol (in press)
Gynecology Division
191. Kasamatsu T, Shiromizu K, Takahashi M, Matsumoto K, Shirai T. Analysis of initial site and spread pattern in endometrial carcinoma:a Japanese experience. Int J Gynecol Cancer 1999;9:470-476.
Head & Neck Surgery and Plastic Surgery Divisions
192. Ota Y, Ebihara S, Ooyama W, Asai M, Saikawa M, Hayashi R, Haneda T, Ebihara M, Kimata T, Uchiyama K, Tunekuni T, Ogawa K. A large maxillofacial prosthesis for total mandibular defect: a case report. Jpn J Clin Oncol 1999;29:256-260.
Hepatobiliary and Pancreatic Surgery Division
193. Fujii K, Kosuge T, Mukai K, Shimada K, Yamamoto J, Yamasaki S. Localized nodular idiopathic retroperitoneal fibrosis: successful treatment with surgical resection. Pancreas 1999;19:213-5.
194. Nakayama H, Takayama T, Makuuchi M, Yamasaki S, Kosuge T, Shimada K, Yamamoto J. Resection of peritoneal metastases from hepatocellular carcinoma. Hepato-Gastroenterol 1999;46:1049-52.
195. Ochiai T, Takayama T, Inoue K, Yamamoto J, Shimada K, Kosuge T, Yamazaki S, Makuuchi M. Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function. Hepato-Gastroenterol 1999; 46:1885-9.
196. Okano K, Yamamoto J, Moriya Y, Akasu T, Kosuge T, Sakamoto M, Hirohashi S. Macroscopic Intrabiliary Growth of Liver Metastases from Colorectal Cancer. Surgery 1999;126:829-834.
197. Shimada K. Yamamoto J. Kosuge T. Sugawara Y. Yamasaki S. Sakamoto M. Adenocarcinoma confined to a cholesterol polyp of the gallbladder. Am J Gastroenterol 1999;94:2568-9.
198. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 1999;178:275-281.
199. Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Should hepatoma be treated with hepatic resection or transplantation? Cancer 1999;86:1151-8.
200. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Brit J Surg 1999;86:332-7.
201. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M. Anterior transhepatic approach for isolated resection of the caudate lobe of the liver. World J Surg 1999;23:97-101.
202. Fujii K, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Kanai Y. Resection of liver metastases after pancreatoduodenectomy: Report of seven cases. Hepato-Gastroenterol (in press).
203. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (in press).
204. Matsuo M, Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Sakamoto M, Takayama T, Makuuchi M. Resection of liver granulomas under a diagnosis of metastaes from breast cancer. Abdomimal Imaging (in press).
205. Shimada K, Yamamoto J, Kosuge T, Sugawara Y, Yamasaki S. Complete drainage of pancreatic juice from the cut edge of the pancreas after subtotal left-side pancreatectomy. Hepato-Gastroenterol (in press) .
206. Sugawara Y, Takayama T, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg (in press).
207. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Sakamoto M. Cystic liver metastases from colorectal cancer. J Surg Oncol (in press).
Neurosurgery Division
208. Nagane M, Asai A, Shibui S, Oyama H, Nomura K, Kuchino Y. Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs. Jpn J Clin Oncol 1999;29:527-534.
209. Oyama H, Ohsuga M, Tatsuno Y, Katsumata N. Evaluation of the psycho-oncological effectiveness of the bedsidewWellness system. CyberPsychology Behavior 1999;2:81-84.
210. Oyama H, Ohsuga M, Tatsuno Y, Katsumata N. VR reproduces wellness for cancer patients. Computer Graphics 1999;33:27-28.
211. Shibui S. How to manage metastatic brain tumors. Jpn J Clin Oncol 1999;29:243-244.
212. Shibui S, Tanaka M, Ino Y, Nomura K, Fujita T. Three-dimensional images by helical CT scan with intra-arterial injection of diluted contrast medium. Jpn J Clin Oncol 1999;29:270-271.
213. Tanaka M, Shibui S, Nomura K, Nakanish Y. Pineal ganglioneuroblastoma in an adult. J Neuro-Oncology 1999;44:169-173.
214. Tanaka M, Shibui S, Nomura K, Nakanishi Y. Brain metastases from adenoendocrine carcinoma of the common bile duct: a case report. Jpn J Clin Oncol 1999;29:252-255.
Ophthalmology Division
215. Kaneko A. Japanese contributions to ocular oncology. Int J Clin Oncol 1999;4:321-326.
Orthopedic Division
216. Kito M, Umeda T, Koyama T. Two giant cell tumors asising from the ribs:Two case reports. Int J Clin Oncol 1999;4:107-111.
217. Masui F, Yoshihiro M, Ryohei Y, Nakanishi Y, Hasegawa T, Kanai Y, Beppu Y, Hirohashi S, Fujii K, Shimoda T. Synovial sarcoma, histologically mimicking primitive neuroectodermal tumor/Ewing's sarcoma at distant site. Jpn J Clin Oncol 1999;29:438-441.
Thoracic Surgery Division
218. Asamura H. Arrhythmias, pulmonary edema, heart failure, and cardiac herniation. Chest Surg Clinic North Am 1999;9:527-541.
219. Asamura H. Thoracoscopic procedures for intrathoracic diseases: a present status. Respirol 1999;4:9-17.
220. Asamura H, Ando M, Matsuno Y, Shimosato Y. Histopathologic prognostic factors in resected lung adenocarcinomas: Is nuclear DNA content prognostic? Chest 1999;115:1018-1024.
221. Asamura H, Ginsberg R. Treatment for small-cell lung cancer: Surgery. In: Hansen H, ed. IASLC Textbook of Lung Cancer. London: Martin Dunitz, 1999:243-249.
222. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Extent of systematic lymph node dissection for non-small cell lung carcinomas based on a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 1999;117:1102-1111.
223. Naruke T, Downey R. Surgical techniques in the management of lung cancer. In: Hansen H, ed. IASLC Textbook of Lung Cancer. London: Martin Dunitz, 1999:363-380.
224. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Carcio-thorac Surg 1999;6:17s-24s.
225. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. VATS lobectomy for lung cancer. Asian J Surg 1999;22:33-40.
226. Okano K, Kondo H, Tsuchiya R, Naruke T, Sato M, Yokoyama R. Spinal epidural abscess associated with epidural catheterization: report of a case and a review of the literature. Jpn J Clin Oncol 1999;29:49-52.
227. Yoshida J, Kondo H, Akao M. Computerized antibiogram for methicillin-resistent Staphylococcus aureus in chest surgery. JJTCVS 1999;47:368-376.
228. Korst R, Tsuchiya R. Treatment of NSCLC: Surgery. In: Hansen H, ed. IASLC Textbook of Lung Cancer. London: Martin Dunitz, 1999:185-200.
229. Asamura H, Nakayama H, Kondo H, Tsuchiya R. Management of the broncial stump in pulmonary resections: a review of 533 consecutive recent broncial closures. Eur J Cardio-thorac Surg (in press)
Urology Division
230. Akakura K, Isaka S, Akimoto S, Ito H, Okada K, Hachiya T, Yoshida O, Arai Y, Usami M, Kotake T, Tobisu K, Ohashi Y, Sumiyoshi Y, Kakizoe T, Shinazaki Y. Long-term results of a randomized trial for the treatment of stage B2 and C prostate cancer:Radical prostatectomy versus external beam radiation therapy with a common endocreine therapy in both modalities. Urology 1999;54:313-318.
231. Fujimoto H, Wakao F, Moriyama N, Tobisu K, Sakamoto M, Kakizoe T. Alveolar architecture of clear cell renal carcinomas (<5.0cm) show high attenutation on dynamic CT scanning. Jpn J Clin Oncol 1999;29:198-203.
232. Harabayashi T, Kanai Y, Yamada T, Sakamoto M, Ochiai A, Kakizoe T, Koyanagi T, Hirohashi S. Reduction of intergrin b and enhanced migration on laminin in association with intraepithelial spreading of urinary bladder carcinomas. J Urol 1999:1364-1394.
233. Horie S, Aruga S, Kawamata H, Okui N, Kakizoe T. Biological role of HGF/MET pathway in renal cell carcinoma. J Urol 1999:990-997.
234. Horie S, Tobisu K, Fujimoto H, Doi N, Kakizoe T. Urinary incontinence after non-nerve-sparing radical prostatectomy with neoadjuvant androgen deprivation. Urology 1999;53:561-567.
235. Richie J, Bono A, Denis L, Jewett M, Kakizoe T, Shirai T, ten Kate F. Tumor, nodes, metastatasis (TNM) classification of bladder cancer. Urologic Oncol 1999;4:90-93.
